T
We officially combined with Bristol Myers Squibb to advance our precision oncology platform for patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for cancer patients. For more information on the acquisition, read our press release at: bit.ly/3Uccbu8
Investor insights
Funding rounds participated in
$460M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2013
Funding rounds raised
Total raised
$460M
from investors over 1 rounds
T
Turning Point Therapeutics raised $460M on November 26, 2020